Patents by Inventor Michael Southall

Michael Southall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200188240
    Abstract: A personalized topical application patch includes a patch substrate having a plurality of isolated regions; and one or more active benefit agents disposed at least one of the plurality of isolated regions.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 18, 2020
    Inventors: Jonathan Hansen, Peyton Hopson, Dianne Rossetti, Michael Southall
  • Patent number: 9629794
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.
    Type: Grant
    Filed: September 23, 2014
    Date of Patent: April 25, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Michael Southall, Samantha Tucker-Samaras
  • Patent number: 9375395
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: June 28, 2016
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Michael Southall, Samantha Tucker-Samaras
  • Patent number: 9370474
    Abstract: The present invention relates to hexylresorcinol/water concentrates that are high in clarity, easily handled, and readily blended with other ingredients to form skin care compositions.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: June 21, 2016
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Kalonda Tymika Johnson, John Lemmo, Michael Southall, Ping Wen
  • Patent number: 9289361
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a non-retinoid collagen promoter.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: March 22, 2016
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Thierry Oddos, Michael Southall, Samantha Tucker-Samaras
  • Publication number: 20150359742
    Abstract: A powder is disclosed including core/shell particles having an average particle size of less than 1000 microns, each particle contains a liquid core that is substantially free of water and includes a polar liquid having a percent surface polarity of at least 24% and a shell comprising hydrophobic particles; and at least one second powder comprising a benefit agent. The powder can be used to topically administer the active ingredient to a human or animal.
    Type: Application
    Filed: June 1, 2015
    Publication date: December 17, 2015
    Inventors: Ali Fassih, Chong Jin Loy, Michael Southall, Ying Sun
  • Patent number: 9173913
    Abstract: Provided are compositions comprising an extract of Paulownia tomentosa wood and methods of use thereof.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: November 3, 2015
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Khalid Mahmood, Claude Saliou, Michael Southall
  • Patent number: 9168207
    Abstract: Provided are compositions comprising an extract of Paulownia tomentosa wood and methods of use thereof.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: October 27, 2015
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Chong Jin Loy, Khalid Mahmood, Claude Saliou, Michael Southall
  • Patent number: 9168219
    Abstract: Provided are compositions comprising an extract of Paulownia tomentosa wood and methods of use thereof.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: October 27, 2015
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Simarna Kaur, Khalid Mahmood, Claude Saliou, Michael Southall
  • Publication number: 20150064292
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.
    Type: Application
    Filed: September 23, 2014
    Publication date: March 5, 2015
    Inventors: Simarna Kaur, Michael Southall, Samantha Tucker-Samaras
  • Patent number: 8916209
    Abstract: A method of making a low molecular weight fraction of Phyllanthus niruri is provided. Such low molecular weight fraction is particularly useful for treating the signs of skin aging.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: December 23, 2014
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Michelle Garay, Simarna Kaur, Michael Southall, Ping Wen
  • Patent number: 8906432
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a non-retinoid collagen promoter.
    Type: Grant
    Filed: October 2, 2009
    Date of Patent: December 9, 2014
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Simarna Kaur, Thierry Oddos, Michael Southall, Samantha Tucker-Samaras
  • Patent number: 8834943
    Abstract: The present invention features compositions comprising at least one compound of the formula I or formula II: wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, or a cosmetically acceptable salt thereof, and the use thereof.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: September 16, 2014
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Michael Southall, Katharine Martin, Phyllis Mitchell, Menas Kizoulis, Neena Tierney, Elvin R. Lukenbach, Binoy K. Bordoloi
  • Patent number: 8758838
    Abstract: Provided are anti-inflammatory compositions comprising (a) an anti-inflammatory agent selected from the group consisting of olive leaf extract, holly herb, sappan wood, feverfew, and combinations of two or more thereof, and (b) an anti-inflammatory agent comprising at least one lipophilic aminoacid and at least one metal salt. Also provided are personal care products comprising such compositions, and methods of use thereof.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: June 24, 2014
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Jean Holland, Janeta Nikolovski, Peter Lyte, Michael Southall, Vivian Zhu
  • Publication number: 20140147523
    Abstract: The present invention relates to compositions comprising extracts of Solanum esuriale and/or Solanum glaucophyllum and methods of treating skin, e.g, dry skin, xerotic skin, skin having a compromised barrier, or skin in need of anti-aging treatment using said compositions.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 29, 2014
    Applicant: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Khalid Mahmood, Kurt Reynertson, Meghan Russell, Michael Southall
  • Patent number: 8697152
    Abstract: Provided are anti-inflammatory compositions comprising (a) an anti-inflammatory agent selected from the group consisting of olive leaf extract, holly herb, sappan wood, feverfew, and combinations of two or more thereof, and (b) an anti-inflammatory agent comprising at least one lipophilic aminoacid and at least one metal salt. Also provided are personal care products comprising such compositions, and methods of use thereof.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: April 15, 2014
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Jean Holland, Peter Lyte, Michael Southall, Vivian Zhu
  • Patent number: 8318217
    Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and an anti-inflammatory compound. The anti-inflammatory compound is not an NF?B-inhibitor and has an IC50 of about 70 ?g/ml or less.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: November 27, 2012
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Simarna Kaur, Michael Southall, Samantha D. Tucker-Samaras, Claude Saliou, Khalid Mahmood
  • Patent number: 8278359
    Abstract: The present invention features compositions comprising at least one compound of the formula I or formula II: wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, or a cosmetically acceptable salt thereof, and the use thereof for treating acne and reducing the appearance of oil or pores on the skin.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: October 2, 2012
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Michael Southall, Katharine Martin, Elvin R. Lukenbach, Binoy K. Bordoloi, Menas Kizoulis, Apostolos Pappas, Catherine Stubler Salerno
  • Patent number: 8221046
    Abstract: The present invention features compositions comprising at least one compound of the formula I or formula II: wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, or a cosmetically acceptable salt thereof, and the use thereof.
    Type: Grant
    Filed: September 9, 2005
    Date of Patent: July 17, 2012
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Michael Southall, Katharine Martin, Phyllis Mitchell, Menas Kizoulis, Neena Tierney, Elvin R. Lukenbach, Binoy K. Bordoloi
  • Publication number: 20120148633
    Abstract: The present invention relates to galvanic particulates, their methods of manufacture and uses in treatments are described. The galvanic particulates may be binary or tertiary galvanic particulates, for example, containing multiple layers or phases of conductive materials.
    Type: Application
    Filed: March 25, 2010
    Publication date: June 14, 2012
    Inventors: Ying Sun, Jue-Chen Liu, Michael Southall, Luiz Arthur Bonaci Tessarotto, Leon B. Kriksunov